This study describes the biochemical and functional characterization of a new metalloproteinase named BbMP-1, isolated from Bothrops brazili venom. BbMP-1 was homogeneous on SDS-PAGE, presented molecular mass of 22,933Da and pI 6.4. The primary structure was partially elucidated with high identity with others metalloproteinases from Viperidae venoms. The enzymatic activity on azocasein was evaluated in different experimental conditions (pH, temperature). A significant reduction in enzyme activity after exposure to chelators of divalent cations (EDTA), reducing agents (DTT), pH less than 5.0 or temperatures higher than 45 C was observed. BbMP-1 showed activity on fibrinogen degrading Aa chain quickly and to a lesser extent the Bb chain. Also demostrated to be weakly hemorrhagic, presenting however, significant myotoxic and edematogenic activity. The in vitro activity of BbMP-1 against Plasmodium falciparum showed an IC 50 of 3.2 ± 2.0 mg/mL. This study may help to understand the pathophysiological effects induced by this group of toxin and their participation in the symptoms observed in cases of snake envenomation. Moreover, this result is representative for this group of proteins and shows the biotechnological potential of BbMP-1 by the demonstration of its antiplasmodial activity.
Snake venom metalloproteinases (SVMPs) (EC 3.4.24) comprise a complex family of zinc-dependent endoproteases, also called zinc metalloproteinases. They are considered some of the most abundant and numerous constituents, composing between 11 and 65% of total venom protein (Calvete et al., 2007; Fox and Serrano, 2008; Terra et al., 2009 ). Their presence is not restricted to Viperidae, being also observed, although to a lesser extent, in the Colubridae (OmPraba et al., 2010; Weldon and Mackessy, 2012) and Elapidae families (Fern andez et al., 2011; Kumar et al., 2011) .
SVMPs are phylogenetically most closely related to the mammalian ADAM (a disintegrin and metalloproteinase) and ADAMTS (ADAM with thrombospondin type-1 motif) families of proteins and, together with them, constitute the M12B clan of metalloendopeptidases (Takeda et al., 2012) . SVMPs display a wide variety of biological activities such as hemorrhage, inhibition of platelet aggregation, coagulopathy, myonecrosis and inflammatory responses (Fox and Serrano, 2005; Guti errez et al., 2005; Teixeira et al., 2005) . These activities are associated with the presence or absence of additional domains besides proteinase domains such as disintegrin and disintegrin-like domains, cysteine domains, and a lectin-binding domains that make up the three different classes of SVMPs called P-I, P-II and P-III (Fox and Serrano, 2008) .
P-I metalloproteinases make up the smallest (molecular mass) SVMP class. This class of enzymes contains a pro-domain and a proteinase domain, presents molecular masses between 20 and 30 kDa and displays fibrinogen and fibrinolytic activities (Akao et al., 2010; Gir on et al., 2013; Markland and Swenson, 2013) . Although P-I SVMPs are known for their proteolytic, apoptotic, myonecrotic and inflammatory activities, the effect of P-I SVMPs against Plasmodium falciparum had not been reported until now. In this study, the biochemical and functional characterization of a new metalloproteinase (EC 3.4.24) BbMP-1, isolated from Bothrops brazili venom was described.
Material and methods

Venom
A venom pool obtained from adult specimens of the B. brazili snake was acquired from Serpent ario Bioagents de Batatais eSP. Dehydrated crude venom was maintained at 8 C. Prior to the experiments, the venom solutions were filtered through a cellulose ester membrane of 0.22 mm average pore size (Millipore Ind. Com. Ltda, Brazil).
The licenses for scientific purposes are from Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renov aveis e IBAMA and Instituto Chico Mendes de Conservação da Biodiversidade e ICMBio. Numbers: 11094-2, 11094-1, 10394-1 and 15484-1.
Animals
Male Swiss mice (18e20 g) were housed in temperaturecontrolled rooms and received water and food ad libitum until used. Animal care was in accordance with the guidelines of the Brazilian College for Animal Experimentation (COBEA) and was approved by Committee for Ethics in Animals Utilization of IPEPATRO/FIOCRUZ-RO (Process nº 001/2012).
Purification of the metalloproteinase
Approximately 50 mg of B. brazili venom was solubilized in 1 mL of 50 mM ammonium bicarbonate, pH 8.0, clarified by centrifugation at 5.900 Â g for 10 min at room temperature and applied to a column containing CM-Sepharose FF resin (GE Healthcare Lifesc.) (1.0 Â 40.0 cm) previously equilibrated with the same buffer. Samples were eluted in a linear gradient from 50 to 500 mM ammonium bicarbonate at a flow of 1.0 mL/min. The eluted fractions were monitored at 280 nm. The purity of BbMP-1 was assessed by high pressure liquid chromatography on a reverse phase column (RP-HPLC). Therefore, the fraction was solubilized in aqueous trifluoroacetic acid (TFA) 0.1% (v/v) and applied to a C18 column (Discovery 4.6 cm Â 25.0 cm, 4 mM e Supelco) previously equilibrated with this buffer solution and eluted using a linear gradient from 0 to 70% solution of TFA 0.1% (v/v) acetonitrile for 10 column volumes (CV) at a flow rate of 1 mL/min. The eluted fractions were monitored at 215 nm. The purification procedure was performed in an € AKTA purifier 10 (GE Healthcare Lifesc.).
Biochemical characterization
The molecular mass (Mr) of BbMP-1 was determined by SDS-PAGE (12.5%) as described by (Laemmli, 1970) after staining with Coomassie Blue R-250 2.5%. Moreover, the molecular mass was confirmed by mass spectrometry performed in MALDI (matrix assisted laser desorption ionization) with two TOF analyzers (AXIMA TOF 2 Shimadzu Biotech) operating in linear mode using a saturated solution of sinapinic acid as a matrix ionization. The isoelectric point of BbMP-1 was determined by twodimensional electrophoresis as previously described (Da Silva et al., 2012) with modifications. Briefly, the sample was solubilized in rehydration solution (7 M urea, 2 M thiourea, 2.0% Triton X-100, 1.0% immobilized pH gradient (IPG buffer ® , GE Healthcare Lifesc.) buffer and 0.002% bromophenol blue) and applied on 13 cm polyacrylamide strips with a pH gradient from 3.0 to 10.0 immobilized in a non-linear way (Immobiline ® DryStrip). Isoelectric focusing was performed in a III IPGphor (GE Healthcare LifeSc.) System. After isoelectric focusing, the sample was reduced and alkylated and the strip positioned in the upper portion of 12.5% SDS-PAGE gel to perform the second dimension (30 mA, 210 min). The gel was stained with 2.5% Coomassie Blue R-250 and the image obtained with the Image Scanner III ® and analyzed using the software IQTL (GE Healthcare LifeSc.).
Enzymatic hydrolysis
BbMP-1 was reduced with 20 mM dithiothreitol (DTT) in 50 mM ammonium bicarbonate for a period of 1 h at 30 C. For alkylation of the thiol groups of cysteine residues the reduced protein was incubated with 150 mM iodoacetamide in 50 mM ammonium bicarbonate for 1 h at 30 C protected from light. After this step, the protein was subjected to digestion by modified trypsin (Sequencing grade modified ® ) for 18 h at 37 C protected from light. The excess of the reagent and electrolytes were removed with the use of a C-18 resin (Proxeon Stage tip ® ) and eluted with 70% acetonitrile/0.1% TFA. The samples were lyophilized and dissolved in 0.1% formic acid.
Protein sequence identification
Spectrometric analysis was performed on a NanoAcquity HPLC (Waters) coupled to a mass spectrometer OrbitrapVelos (Thermo Scientific). Protein was digested with trypsin and an aliquot of the digest was injected and separated on a C18 column (75 micron Hi, 10 cm, NanoAcquity, 1.7 mM BEH column, Waters). The peptides were eluted with the following gradient: 1e40% B in 20 min, followed by 40%e60% B gradient in 5 min a flow of 250 nL/min. Solution A consisted of 0.1% formic acid (v/v) in water and, solution B 0.1% formic acid (v/v) in acetonitrile. The peptide masses (m/z 300e1700) were measured in the Orbitrap 60,000 at a resolution of m/z 400. The most abundant peptides were selected and fragmented in the collision cell HCD with normalized collision energy (NCE) of 40% and nitrogen as the collision gas. The fragments were detected in the Orbitrap with a resolution of 7500FWHM 400 m/z. Data were collected with Thermo Xcalibur (v.2.1.0.1140).
Database search was performed against NCBiSerpentes database in the Proteome Discoverer software (Thermo Scientific) using Mascot as search engine. The search parameters were: 2 missed cleavages, fixed modifications: carbamidomethyl of cysteine; variable modifications: oxidation for methionine and pyro-Glu for Nterminal glutamine; peptide tolerance: 10 ppm for MS spectra and 0.05 Da for MS/MS spectra; and semy trypsin as enzyme. The Percolator node was used in order to discriminate correct from incorrect peptide spectrum matches using the q-value (FDR) to improve the number of confidently identified peptides at a given false discovery rate. The results have been filtered so only high confidence peptides (FDR 0.01) are considered for identification results.
Molecular modeling by homology
The initial three-dimensional model of BbMP-1 was generated by the technique of modelling by threading (Bowie et al., 1991; Chothia and Lesk, 1986; Godzik et al., 1992; Sander, 1995, 1993; Jones et al., 1992) deployed on the server HHPred. 52 alignments were generated with the primary structure of proteins available in the database Protein Data Bank (PDB) using the global alignment method and all other options adjusted according to the standard program.
Molecular dynamics
After obtaining the three-dimensional model of BbMP-1, a molecular dynamics (MD) simulation was performed in order to refine the structure obtained. The MD simulations were performed using the program GROMACS 4.5.4 (Berendsen et al., 1995; Lindahl et al., 2001) employing the explicit solvation model using the water model Single Point Charge (SPC) (Berendsen et al., 1981) to represent water molecules. The protonation states of charged groups were adjusted to pH 7.0 and counter ions were added to neutralize the system. The force field Gromos (Van Gunsteren et al., 1996) , a periodic cubic box with 1 nm minimum distance between all atoms of the protein and the walls of the box with constant pressure and temperature, was employed for the MD simulations.
An atom of Zn 2þ in the catalytic site of the enzyme was added to assess the stability of the 3D structures obtained. An alignment between the three-dimensional structures of the protein studied and the mold selected to obtain the atomic coordinates of zinc was performed and a new model was generated. The dimensional alignment was performed using the program PyMOL 0.99c. After the initial model with the addition of Zn 2þ , a simulation of MD was performed using all procedures described above. Therefore, two models of the metalloproteinase studied were obtained. The structural analysis and validation of the obtained structures were performed using the Ramachandran map generated by the server Rampage (Lovell et al., 2003) and the pseudo-energy profiles were analyzed using the programANOLEA (Melo and Feytmans, 1998; Melo et al., 1997) .
Enzymatic activity
The enzymatic activity was assessed using azocasein as substrate as described by Gomes and coworkers (2011) with modifications. Briefly, 100 mL of azocasein (1 mg/mL in 50 mM TBS pH 8.0) was added to microtubes containing 7 mL of a solution containing different concentrations of BbMP-1. Immediately, the samples were incubated for 1 h at 37 C and the reaction was stopped by adding 100 mL 20% TCA (trichloroacetic acid) for 30 min at room temperature. After this, the tubes were centrifuged at 3,000 Â g for 20 min and 100 mL of the supernatant were dispensed in 96-well plate and an equal volume of 500 mM sodium hydroxide was added. The optical density was determined using an Eon Microplate Spectrophotometer (Bio Tek Instruments, Inc) and one caseinolytic activity unit was defined as the increase in 1 mUA440 nm/min and expressed as U/mg protein. All assays were performed in triplicate. The influence of pH and temperature on enzymatic activity was assessed in a range of 4.0e9.0 and 25 C to 70 C, respectively. Furthermore, the influence of inhibitors (5 mM EDTA, 5 mM DTT and 10 mM PMSF) on enzyme activity was also evaluated. For this purpose, 10 mg of BbMP-1 was preincubated for 30 min at different pH conditions, temperatures, or with inhibitors and the enzymatic activity was determined as described above.
Fibrinogenolytic activity
The fibrinogenolytic activity was determined as previously described (Rodrigues et al., 1998) with modifications. Briefly, samples of bovine fibrinogen (1 mg/mL) were incubated with 10 mg of BbMP-1 for 15, and 30 min, 1, 3, 6 and 12 h at 37 C. The reaction was stopped by addition of 0.5 mM TriseHCl buffer, pH 8.0 containing 20% glycerol, 4% SDS, 0.05% bromophenol blue, and 0.3% DLdithiothreitol in a 1:1 ratio, followed by incubation for 18 h after the fibrinogen digests were analyzed on 10% SDS-PAGE and stained with 2.5% Coomassie Blue R-250.
Hemorrhagic activity
The hemorrhagic activity was assessed as described (Nikai et al., 1984) . Groups of three male Swiss mice (28e32 g) were injected intradermally in the dorsal region with 50 mL of 0.15M sodium chloride containing 50 mg of BbMP-1. Controls received 50 mL of 0.15M sodium chloride. After three hours, the animals were euthanized by cervical dislocation and the skin removed. The hemorrhagic area was determined with the software Image Klonk Mensurement 12.2.1.9 and the minimum hemorrhagic dose (MHD) was defined as the amount of protein capable of inducing a hemorrhagic area of 1 cm 2 .
Edematogenic activity
Swiss mice (18e20 g) were injected in the right hind paw with 50 mg of BbMP-1 diluted in 50 mL of phosphate buffered saline (PBS).
Control animals were injected in the left hind paw with only PBS. The paw volume was measured using a thickness gauge (Mitutoyo 7301) at 30, 60, 120 and 180 min after toxin injection and values were compared (St abeli et al., 2006).
Myotoxic activity
Swiss mice (18e20 g) were injected in the right gastrocnemius muscle with 50 mg of BbMP-1 or 50 mg of B. brazili venom solubilized in 50 mL of phosphate buffered saline (PBS). Control groups received only PBS. After 3 h, the blood was collected from the retroorbital plexus and centrifuged at 2300 Â g for 5 min. Serum was separated and used to measured creatine kinase (CK) using a commercial kit (CK-NAC Labtest) (St abeli et al., 2006) . The reading was performed in an Eon Microplate spectrophotometer (Bio Tek Instruments, Inc.) at a wavelength of 340 nm.
2.14. In vitro activity of the metallprotease against P. falciparum
The in vitro activity of BbMP-1 and B. brazili venom was evaluated against P. falciparum (clone W2, chloroquine resistant) cultured in human erythrocytes (blood group Aþ) using RPMI 1640 medium supplemented with 10% human serum blood group A þ , 2% glutamine, and 7.5% NaHCO 3 as previously described (Trager and Jensen, 1976 ) with a few modifications as follows. The ring stages were synchronized in sorbitol (Lambros and Vanderberg, 1979) , and immediately incubated with the compounds test, previously solubilized in 0.05% DMSO (v/v) (Sigma, USA), at various concentrations (20e0.001 ug/mL). The test was performed in triplicate with 0.05% parasitemia and 1.5% hematocrit. The results were compared with control cultures in the absence of drugs, and chloroquine was also used in each experiment as an antimalarial control. The anti-P. falciparum effects of the molecules were measured using an immunoenzymatic test, as previously described (Noedl et al., 2003) . For the latter we used commercially available monoclonal antibodies (MPFM ICLLAB-55A
® and MPFG55P ICL-LAB ® , USA) that are specific to a histidine-and alanine-rich parasite protein (HRPII). The binding of HRPII antibodies was quantified at 450 nm using a spectrophotometer (SpectraMax340PC 384 , Molecular Devices). The half-maximal drug inhibitory response (IC 50 ) was estimated by curve fitting using software from the OriginLab Corporation (Northampton, MA, USA).
Cytotoxicity effect
The cytotoxicity of BbMP-1 and B. brazili venom was assessed using a human hepatomacell line (HepG2) cultured in 75-cm 2 sterile flasks containing RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf serum and 40 mg/L gentamicineunder 5% CO 2 atmosphere at 37 C. The confluent cell monolayer was washed with culture medium, trypsinized, distributed in a flatbottomed 96-well plate (5 Â 10 3 cells/well), and incubated for 18 h at 37 C for cell adherence (Denizot and Lang, 1986) . The compounds (20 mL) were added to each well at various concentrations (1000e1 mg/mL) and incubated for 24 h in a 5% CO 2 atmosphere at
bromide] solution (5 mg/mL; 20 mL/well) was added to evaluate mitochondrial viability, and the plates were incubated for a further 3 h. The supernatant was carefully removed and 100 mL DMSO was added and mixed to solubilize the formazan crystals formed. The optical density was determined at 570 and 630 nm (background) (SpectraMax340PC 384 , Molecular Devices). The cell viability was expressed as percentage of the control absorbance in the untreated cells after subtracting the appropriate background. The minimum lethal dose for 50% of the cells (MLD 50 ) was determined as previously described (Do C eu de Madureira et al., 2002) . The selectivity index (SI) was calculated as the ratio between cytotoxicity against the hepatoma cells (MDL50) and the anti-P. falciparum activity (IC 50 ). SI higher than 10 was considered non-toxic (B ezivin et al., 2003) .
Statistical analysis
Means and S.E.M. of all data were obtained and compared by one-way ANOVA, followed by a Tukey test with significance probability levels of less than 0.05.
Results
Purification and metalloproteinase biochemical characterization
B. brazili snake venom was applied to CM-Sepharose FF and 10 peaks were obtained (1e10) (Fig. 1 A) . The peaks were submitted to functional and biochemical analyses and peak 4 was selected presenting proteolytic activity on azocasein and protein content of approximately 23 kDa, consistent with PI SVMPs (Fig. 1B) . The purity confirmed by RP-HPLC showed a satisfactory purity (Fig. 1C) . The SDS-PAGE analysis under non-reducing and reducing conditions confirmed the homogeneity of the protein and single bands were observed with a molecular mass close to 23 kDa, showing its monomeric structure (Fig. 1D ). This fraction was named BbMP-1 and corresponds to 5.3% (m/m) of crude venom showing 140 U/ mg of proteolytic activity on azocasein.
BbMP-1 molecular mass was confirmed by mass spectrometry in MADI-TOF and a peak corresponding to the mass of 22,933Da was identified and assigned to be BbMP-1 (Fig. 2C ). The analysis of 2D SDS-PAGE indicated that BbMP-1 has a slightly acidic pH with an isoelectric point (pI ¼ 6.4) (Fig. 2B ).
Structural characterization
BbMP-1 was subjected to tryptic digestion and 13 peptides were identified by homology with 3GBO_A (GI:259090190) ( Table 1) . Protein sequences were aligned using the program Clustal X 1.8, with an evident high degree of similarity with P-1 SVMPs (Fig. 3) .
The initial BbMP-1 three-dimensional model was generated using the threading modeling technique. Fifty-two alignments were generated with the protein's primary structure available in protein banks using the global alignment method and all other options were adjusted according to the standard program. The metalloproteinase A chain of Crotalus atrox (VAP1 PDB ID: 2ero) was selected as the template for modeling. The sequence used for molecular modeling studies was defined from the fragments generated by sequencing. The regions whose sequences were not defined using that method were derived by homology and in silico simulations.
Simulations were conducted with models of the protein alone and the protein with the incorporation of a zinc ion at the active site of the enzyme. The stereochemical quality and energy of the two models have been analyzed by comparing the results of the Ramachandran plot, which show a better quality model with zinc, with about 97.6% of the residues in favorable or allowed regions. This result is in agreement with the analysis performed using the program ANOLEA (Atomic Non-Local Environment Assessment) which showed 10.2% of the amino acids as having high energy values (Table 1) .
Enzymatic characterization
The activity of BbMP-1 on azocasein was evaluated, showing dose-dependent activity (Fig. 5A) . Also, BbMP-1 showed limited thermal stability against pH changes with loss of activity when exposed to temperatures above 45 C (Fig. 5D ), or pH less than 5.0 (Fig. 5C) .
The enzymatic activity of BbMP-1 in the presence of inhibitors (EDTA, DTT or PMSF) was also evaluated. In the presence of EDTA or DTT the enzymatic activity of BbMP-1 was significantly reduced, while PMSF was unable to alter the enzyme kinetic characteristics (Fig. 5B) .
Fibrinogen was also used as substrate for enzymatic characterization of BbMP-1. Incubation of BbMP-1 with fibrinogen for different periods of time showed that the fibrinogen aA-chain is degraded very quickly (30 min), while degradation of the fibrinogen Bb-chains occurs more slowly (Fig. 6) .
Functional characterization
The myotoxicity effect of BbMP-1 on mice was evaluated by creatine kinase (CK) serum levels. The i.m. injection of BbMP-1 caused an extravasation of CK of 2320 ± 670 U/L, significantly different from the control (Fig. 7B) . Furthermore, BbMP-1 was able to induce a rapid edematogenic response that persisted for more than 3 h (Fig. 7A) . Also, BbMP-1 presented low hemorrhagic activity with a Minimum Hemorrhagic Dose (MHD) of 34.6 mg ( Fig. 7C and   D) .
In vitro antiplasmodial activity
BbMP-1 and B. brazili venom were tested for their antiplasmodial activity against P. falciparum (Table 2) W2 clone (Chloroquine resistant and mefloquine sensitive), by an enzyme immunoassay using monoclonal antibodies directed against the protein HRPII specific to the parasite, which is essential for their survival. Both the BbMP-1 and B. brazili venom were activity and showed low IC 50 levels (0.17 and 3.2 mg/mL respectively) ( Table 2) . Also, the cytotoxic effect of BbMP-1 and B. brazili venom on the HepG2 cell line was assessed by the MTT reduction method. The cytotoxic effect of the B. brazili venom was shown to be rather sharp with a MDL 50 ¼ 31.6 ± 9 mg/mL as compared to BbMP-1 (MDL 50 gt; 200 mg/mL) ( Table 2 ). Both compounds were not toxic, the compound BbMP-1 had the highest SI (182). Chloroquine was the most active compound, with IC 50 of 0.036 ug/mL and SI of 9000.
Discussion
BbMP-1 was purified with high purity by a single chromatographic step on CM-Sepharose. This was possible due to its isoelectric point near neutral (pI ¼ 6.4, Fig. 2B ), which resulted in an experimental condition with minimal residual charge but sufficient to promote an effective separation of BbMP-1 from other acidic (Fig. 1A, fractions 1 to 3) as well as the most basic components (5e10) present in B. brazili venom.
Accordingly, SVMPs PI class are proteins with isoelectric points ranging from slightly acidic, such as BjussuMP-II (pI 6.5) (Marcussi et al., 2007) , to even more alkaline like atroxase which has a pI of approximately 9.6 (Tu et al., 1996) . This amplitude in pI range allows for several methods of purification of these toxins. In this Crude venom of B. brazili was fractioned in a linear gradient from 50 to 500 mM Ambic, pH 8.0, for 5 column volumes. Sample elution was monitored at 280 nm (B) 12,5% SDS-PAGE under reducing conditions. The fractions obtained from CMSepharose were reduced, separated by electrophoresis and stained with 2.5% Coomassie Blue R-250 (MW-molecular protein markers; lane1-10-crude venom chromatographic fractions), (C) chromatographic profile of C-18 high efficiency column. The fourth fraction obtained from CM-Sepharose ® was solubilized in 0.1% TFA and fractionated in 0e100% of 0.1% TFA in acetonitrile. Elution of the samples was monitored at 280 nm (D) 12.5% SDS-PAGE under reducing and non-reducing conditions. The reduced and unreduced portions of the fourth fraction were separated by electrophoresis and stained with 2.5% Coomassie Blue R-250 (MW-molecular protein markers; Lane 1-fraction 4 in non-reducing conditions, 2-fraction 4 in reducing conditions and MW-molecular protein markers). sense, BJ-PI2 which has a pI ¼ 8.0 was obtained using a strategy that combines a molecular exclusion step, followed by another anion exchange (negative selection) (Da Silva et al., 2012) . Already BjussuMP-II which has a pI ¼ 6.5 was isolated after two chromatographic steps (cation exchange followed by hydrophobic interaction) (Marcussi et al., 2007) , both involving ion exchange chromatographic methods.
With respect to functional analysis the obtained fractions on CM-Sepharose FF showed that the proteolytic activity was concentrated in fractions 1, 2, 3 and 4 (data not shown). However, fraction 4 presented the greatest intensity of proteolytic activity. SDS-PAGE analysis showed that molecular masses of fractions 1 to 3 are compatible with other groups of proteins present in snake venoms such as serine proteases and other classes of SVMPs. Structurally, SVMPs can be classified into three groups (P-IeP-III) (Fox and Serrano, 2008) . The PI class is characterized by the presence of only a metalloproteinase domain and a molecular mass between 20 and 30 kDa (Markland and Swenson, 2013) . These characteristics were observed in protein bands present in fractions 2 and 3, but mainly chromatographic fraction 4 of BbMP-1 presented a high level of purity. Still, comparative analysis of SDS-PAGE of the chromatographic fractions and 2D-SDS-PAGE of the crude venom allows us to verify the presence of isoforms of this protease, as evidenced in the two-dimensional electrophoresis spots with varying isoelectric points.
Moreover, electrophoretic analysis of BbMP-1 in reducing and non-reducing conditions showed its monomeric structure (Fig. 1D ) and a relative molecular mass of 23 kDa (Fig. 1B) , confirmed by mass spectrometry (22,933 Da, Fig. 2C ). These characteristics are compatible with PI SVMPs isolated from other species of B. described in the literature, such as BjussuMP-2 (24,000 Da) from Bothrops jararacussu, Atroxlysin-I (23,000 Da) from Bothrops atrox (Sanchez et al., 2010) , BleucMP (23,500 Da) from Bothrops leucurus Fig. 2 . Determination of isoelectric point and mass spectrum: Bidimensional electrophoresis of B. brazili crude venom (A) and BbMP-1 (B). The samples (crude venom and BbMP-1) were subjected to isoelectric focusing in an Imobiline strip ® gel with a pH gradient from 3.0 to 10.0 arranged in a nonlinear way and the second dimension was performed on 12.5% SDS-PAGE. The gel was stained with 2.5% Coomassie Blue R-250. The arrows point to BbMP-1. (C) Mass spectrum of BbMP-1. The protein (BbMP-1) was co-crystallized with a saturated solution of sinapinic acid and the mass spectrum was acquired by matrix-assisted ionization laser (MALDI) in Axima TOF2 mass spectrometer (Shimadzu, Japan) operated in linear mode. Ions numbers mass to charge (M/H) þ 11,520and (MH) þþ 22,933 correspond to BbMP-1. (Gomes et al., 2011) and BmooMPa-I (24,500 Da) from Bothrops moojeni (Bernardes et al., 2008) . The 13 peptide fragments from BbMP-1 obtained by tryptic digestion and sequencing corresponded to about 83% of the protein molecule. Sequence analysis of these fragments revealed a high degree of identity with various PI SVMPs isolated from Bothrops venoms such as BmooMPalpha-I (75%), BjussuMP-II (69%) and BAP1 (65%), among others. These fragments are distributed over a large region of the molecule, leaving two fragments in the central region (X65-X70 and X77-X83) and an important region near the catalytic domain (x141ex169) which consist of the sequence HEXXHXXGXXH, partially elucidated. The first two histidines (H136 and H140) and glutamic acid (E137), which are located in a region of a-helix that forms the floor of the active site, could be evidenced.
The third histidine (H146) that is part of a loop that starts with a highly conserved glycine and forms the right lateral wall of the slit was not identified, but the molecular modeling studies beyond the proper enzyme activity eventually show its presence. Another important aspect is related to the number of cysteine residues observed in PI SVMPs which can be quite variable. In this regard, Trymerelysin II, Acutolysin A and Adamalysin II show seven cysteine residues, whereas BaP-1 and BmooAlpha-1 and BjussuMP-II show six cysteine residues. However in HT2 and fibrolase only three cysteine residues were found. This variation in the number of residues also allows several patterns of disulfide bonds, and thus different tertiary structures. These interactions are important for maintaining the structure of the molecule closely related to the catalytic activity.
In silico three-dimensional structure generated retains peculiar characteristics of the SVMP group of enzymes, clearly showing the ellipsoidal conformation of the catalytic site separating the higher domain from the lower bottom domain (Fig. 4) . The top domain is composed of five b-sheets (bI to bV), where only the fourth (b-IV) is arranged in an antiparallel manner. In addition, five a-helices are present and a-1 is short, consisting of 4e6 amino acid residues and a-2 is long and consists of 16e21 amino acid residues (Gomis-Rüth, 2009). Already the lower domain consists of a single a-helix domain and several loops. The presence of three disulfide bridges (Cys111-Cys190, Cys150-Cys172 and Cys152-Cys157) in the generated models could also be inferred based on homology and structural patterns of disulfide bonds.
In the present study, the inhibitory action of EDTA, PMSF and DTT on the ezymaticactivity of BbMP-1 against azocasein was evaluated. Fig. 5B showed that the activity of BbMP-1 was dramatically reduced when pre-incubated with EDTA. Circular dichroism studies have shown that removal of zinc by chelation indicated changes in the tertiary structure (Sanchez et al., 2010) with a sharp decrease in a-helices content (Bjarnason and Fox, 1994) . In addition, the results generated in the validation of the three-dimensional BbMP-1 model (Table 3) suggest that the incorporation of the ion contributed to a better stereochemistry and energetic adaptation (fit)of the amino acid residues in the molecule. On the other hand, exposure to a selective inhibitor of serine proteases (PMSF) did not significantly alter the effect on enzyme activity. Still, the reduction of enzyme activity with the use of DTT allowed us to infer the presence of disulfide bonds and demonstrated their importance in maintaining the functional structure of the protein molecule.
Besides the action of inhibitors, kinetic parameters of thermal stability in pH changes were evaluated, contributing to enzymatic characterization of BbMP-1. As shown in Fig. 5D , BbMP-1 has limited thermal stability, with a sharp reduction of its activity when exposed to temperatures above 45 C, which is a feature observed in other SVMPs such as BmHF-1 (Torres-Huaco et al., 2010) and BmooMPalpha-I (Bernardes et al., 2008) . This probably occurs because of the disruption of electrostatic interactions and covalent bonds important for maintaining the structure of the enzyme. Furthermore, exposure to pH conditions below 5.0 causes a significant reduction in the catalytic ability of BbMP-1. Acidic pH environments cause changes in the state of protonation of histidine residues and reduce the polarization of the glutamic acid residue, thus influencing the electrostatic interactions between the zinc and the water molecule present in the catalytic site of the enzyme (Abi et al., 2009; Watanabe et al., 2003) , water molecule, responsible for this nucleophilic attack of the carbon in the carbonyl group of the peptide bond.
The fibrinogenolytic activity study of snake venom and isolated proteases was started by Didisheim and Lewis (1956) , demonstrating the applicability of these compounds in medicine as a thrombolytic therapy. Fibrinogen is an abundant glycoprotein in plasma and plays a key role in hemostasis. It displays hexamer formation, comprising three pairs of polypeptide chains termed Aa, Bb and g showing molecular masses of 66,500 Da, 56,000 Da and 47,000 Da, respectively, linked by disulphide bridges. Under physiological conditions, Aa and Bb chains are catalytically processed by thrombin forming two fibrinopeptides A (FPA) and two fibrinopeptides B (FPB), leaving the rest of the molecule intact and allowing for polymerization which leads to fibrin formation.
Unlike thrombin which specifically cleaves the Aa Arg-16 and Bb Arg-14 binding site (Binnie and Lord, 1993; Scheraga, 2004) , apparently, SVMPs process enzymatically the fibrinogen chains in a promiscuous manner (Chen et al., 2008; Siigur et al., 2002; Trummal et al., 2000) , which leads to the production of functionally inactive fragments of fibrinogen and consequently a lack of fibrin clot formation.
In the present study BbMP-1 showed fibrinogenolytic activity on the Aa chain, degrading it very quickly and completely, and may also degrade the Bb chain after about 90 min, while the g chain remained unchanged under the conditions evaluated. This pattern allows the classification of BbMP-1 as an a-fibrinogenase that is also true of several PI SVMPs isolated from others Bothrops sp venoms such as BmooMP-aI (Bernardes et al., 2008) , BmHF-1 (Torres-Huaco et al., 2010) , BpMP-1 (Naves de Souza et al., 2012) , BmooMP-a 2 (De Queiroz et al., 2014) , BpMP-II (Achê et al., 2015) , among others.
Fibrinogenolytic enzymes demonstrate important biotechnological potential and are used to elucidate the structural mechanisms involved in the consumption of fibrinogen and fibrin polymerization in vivo and in vitro as well as in the study of antithrombotic or thrombolytic drugs. PI SVMPs have reduced hemorrhagic activity as compared to class P-II and P-III. However, some are potent inducers of bleeding such as acutolysin A, ruberlysin (HT-2), trimerelysin, and others. This difference in the pattern of hemorrhagic activity does not seem to be related to the proteolytic activity in vitro, since even nonhemorrhagic SVMPs are capable of degrading a variety of substrates including extracellular matrix components (Gir on et al., 2013; Rodrigues et al., 2000; Rucavado et al., 1999) .
In this sense, BbMP-1 can be classified as a weakly hemorrhagic metalloproteinase, with a minimum dose of 34.6 mg causing bleeding, similar to other proteases in the literature (Fig. 7C and D) such as BAP-1, a metalloproteinase isolated from Bothrops asper venom (Guti errez et al., 1995) ; Atroxlysin-I from B. atrox venom (Sanchez et al., 2010) , BthMP from B. moojeni venom (Gomes et al., 2009 ) and BATX-1 isolated from B. atrox venom (Patiño et al., 2010) are three representatives of PI SVMPs isolated from the venom with discrete hemorrhagic activity. In this study, the myotoxic action of BbMP-1 was evaluated by quantification of serum creatine kinase (CK). The results showed that BbMP-1 induced a high level of serum CK when compared to the control group (Fig. 7B) . Unlike myotoxins which have a PLA 2 structure and whose mechanism of damaging muscle tissue is already well established, the mechanism by which SVMPs exert toxic effects on this tissue type is not known. In the literature, the association between the myotoxic and hemorrhagic effects of SVMPs is amply demonstrated, even when the proteases have discrete hemorrhagic activity as observed with BaP1, BleucMP and BthMP, among others.
Edema results from the synergistic action of several components of the venom. It is speculated that in these cases, it occurs primarily in response to a wide variety of inflammatory mediators that induce an increase in vascular permeability, fluid and protein extravasation, and consequently edema (Fernandes et al., 2006; Teixeira et al., 2005) . Moura-da- Silva et al. (1996) have shown that venom hemorrhagic metalloproteinases promote the release of tumor necrosis factor-alpha (TNF-a) from its precursor, suggesting that this group of proteases can mediate the release of various inflammatory mediators. Also, Fernandes et al. (2006) showed that BaP1, besides causing in vitro release of TNF-a, also induces the release of IL-1 in murine models. Among the many actions attributed to IL-1 is the ability to stimulate the production and release of several inflammatory mediators, among them, nitric oxide, extracellular matrix metalloproteinases, eicosanoids and other cytokines, among them TNF-a itself, further increasing the levels of this mediator. Thus BbMP-1's edematogenic effect on animal models was investigated. The results obtained with BbMP-1 showed that this SVMP induces edema (Fig. 7A ), which agrees with the literature.
The importance of biodiversity to human health is constantly highlighted in the literature (Herndon, 2010; Soares et al., 2005) and is easily corroborated if we consider that over 50% of the commercially available therapeutic arsenal is derived from extracted bioactive molecules or use substances of nonhuman origin as models. Therefore, in this study the microbicidal activity of BbMP-1 on P. falciparum was evaluated.
It is important to note that the resistance of P. falciparum to antimalarial has been a major obstacle against malaria, given that the indiscriminate and inappropriate use of these drugs has promoted the selection of multiresistant strains. Thus, the search for therapeutic alternatives, arising from synthetic analogs or alternative sources such as plants and animals, has been the target of investment of several research groups around the world. In this sense, the study of antiplasmodial activity of animal toxins has been conducted for a long time. Guillaume et al. (2004) evaluated the effect of different PLA 2 s isolated from snakes, bees and scorpions, demonstrating the pronounced antimalarial activity of this group of proteins. Quintana et al. (2012) demonstrated that Crotalus durissus cumanensis venom has antimalarial activity, with crotoxin B as active constituent, with an IC 50 of 0.6 g/mL. Still, Castillo et al. (2012) showed in vitro antimalarial activity of both crude venom and Asp49 and Lys49 PLA 2 s from B. asper venom. These authors showed that the antimalarial activity was more pronounced in enzymatically active PLA 2 -Asp49 (1.42 ± 0.56 mg/mL) than in inactive PLA 2 -Lys49 (22.89 ± 1.22 mg/mL); these toxins may exert independent toxic mechanisms on the parasite. In the present study, the antimalarial activity of B. brazili venom and BbMP-1 were assessed on P. falciparum CQ-resistant (clone W2). The results obtained with B. brazili venom and BbMP-1 in vitro showed a marked toxic activity of both venom and toxin with an IC 50 of 0.17 ± 0.01 mg/ mL and IC 50 3.2 ± 2.0 mg/mL, respectively. Taken together, these data corroborate data from the literature that different components of snake venom can, independently or synergistically, exert antimalarial activity in vitro (Castillo et al., 2012; Quintana et al., 2012) .
The liver is a key organ in the development of the malariacausing protozoan cycle which starts with the inoculation of sporozoites by the bite of Anopheles sp female mosquitoes. These sporozoites rapidly enter the bloodstream and reach the liver where they differentiate within hepatocytes into exo-erythrocytes, a replicative form, subsequently giving rise to merozoites which in turn, initiate the erythrocytic stage of the parasite. In addition, the liver is the organ responsible for the metabolism of several drugs and cell lines derived from hepatocytes and has been routinely used in research on molecules with antiplasmodial activities in order to establish a selectivity ratio between the parasite and host cells (Aroonkit et al., 2015; Cohen et al., 2015; Ouattara et al., 2014; Primas et al., 2014) . In this context, the cytotoxic activity induced by B. brazili crude venom and bBMP-1 on human hepatoma cells (HepG2) was also evaluated.
The results showed that B. brazili venom was at least 5 times more toxic than BbMP-1. The selectivity index (SI), found using the ratio between the toxic dose (MDL 50 ) and active concentration (IC 50 ), mathematically represents the selectivity of the drug between the two models tested, mammalian cells and protozoa. In this sense, the results obtained here showed that the toxicicity of both the B. brazili venom (SI ¼ 182) and BbMP-1 (SI ! 67) are more pronounced on the protozoan than on HepG2 cells.
The study of snake venom components may help to understand their role in the envenomation process, and the development of more effective and specific treatments for snakebites. Moreover, the biotechnological potential of the components can be better assessed, and may help to develop new drugs or even serve as tools for bioprospecting. In the present study, the applicability of BbMP-1 as an antithrombotic agent can be detected since this enzyme degrades fibrinogen. Another aspect to be highlighted is the antimalarial activity reported in this paper, noting that this is the first time this feature has been described for SVMPs.
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